Back to Search
CURT LINDLEY, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1518344381Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors.
PMID 18327587·Cancer Chemother Pharmacol·2008
3-trial
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
PMID 17285317·Cancer Chemother Pharmacol·2007
3-trial
Fatal pneumonia among metalworkers due to inhalation exposure to Bacillus cereus Containing Bacillus anthracis toxin genes.
PMID 17205450·Clin Infect Dis·2007
5-case
Enantioselective liquid chromatography-mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasma.
PMID 17855037·J Pharm Biomed Anal·2007
8-other
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.
PMID 17186001·Clin Pharmacol Ther·2007
3-trial
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
PMID 17212999·Clin Ther·2006
6-review
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
PMID 15923800·Am J Clin Oncol·2005
3-trial
Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
PMID 16291713·J Clin Pharmacol·2005
4-observational
Trends in walking for transportation in the United States, 1995 and 2001.
PMID 16164818·Prev Chronic Dis·2005
8-other
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
PMID 16203659·Cancer Invest·2005
3-trial
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.
PMID 15626743·Blood·2005
3-trial
Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.
PMID 15166618·Anticancer Drugs·2004
3-trial
Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.
PMID 14977870·Drug Metab Dispos·2004
8-other
Laboratory analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 2002.
PMID 15109407·Emerg Infect Dis·2004
7-preclinical
First reported prairie dog-to-human tularemia transmission, Texas, 2002.
PMID 15109417·Emerg Infect Dis·2004
7-preclinical
Phase I study of a novel recombinant human soluble thrombomodulin, ART-123.
PMID 15456485·J Thromb Haemost·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1430 TULANE AVE, SL-50
NEW ORLEANS, LA 70112 - Phone
- (504) 988-7809
Quick Facts
- NPI
- 1518344381
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile